nodes	percent_of_prediction	percent_of_DWPC	metapath
Tadalafil—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0544	0.332	CbGbCtD
Tadalafil—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0506	0.308	CbGbCtD
Tadalafil—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0232	0.142	CbGbCtD
Tadalafil—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.0213	0.13	CbGbCtD
Tadalafil—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.0145	0.0885	CbGbCtD
Tadalafil—Hyperhidrosis—Cisplatin—peripheral nervous system neoplasm	0.000668	0.0008	CcSEcCtD
Tadalafil—Liver function test abnormal—Epirubicin—peripheral nervous system neoplasm	0.000667	0.000798	CcSEcCtD
Tadalafil—Rash—Melphalan—peripheral nervous system neoplasm	0.000666	0.000797	CcSEcCtD
Tadalafil—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000666	0.000796	CcSEcCtD
Tadalafil—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000664	0.000794	CcSEcCtD
Tadalafil—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000661	0.00079	CcSEcCtD
Tadalafil—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.00066	0.000789	CcSEcCtD
Tadalafil—Abdominal pain upper—Epirubicin—peripheral nervous system neoplasm	0.00066	0.000789	CcSEcCtD
Tadalafil—Migraine—Doxorubicin—peripheral nervous system neoplasm	0.000658	0.000787	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000656	0.000785	CcSEcCtD
Tadalafil—Discomfort—Etoposide—peripheral nervous system neoplasm	0.000653	0.000781	CcSEcCtD
Tadalafil—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000653	0.000781	CcSEcCtD
Tadalafil—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000646	0.000773	CcSEcCtD
Tadalafil—Nasopharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000646	0.000773	CcSEcCtD
Tadalafil—Face oedema—Doxorubicin—peripheral nervous system neoplasm	0.000645	0.000772	CcSEcCtD
Tadalafil—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000645	0.000771	CcSEcCtD
Tadalafil—Urticaria—Alitretinoin—peripheral nervous system neoplasm	0.000645	0.000771	CcSEcCtD
Tadalafil—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000641	0.000767	CcSEcCtD
Tadalafil—Nausea—Topotecan—peripheral nervous system neoplasm	0.000641	0.000767	CcSEcCtD
Tadalafil—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000639	0.000765	CcSEcCtD
Tadalafil—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000639	0.000765	CcSEcCtD
Tadalafil—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000636	0.000761	CcSEcCtD
Tadalafil—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000636	0.000761	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.00063	0.000754	CcSEcCtD
Tadalafil—Infection—Etoposide—peripheral nervous system neoplasm	0.000629	0.000753	CcSEcCtD
Tadalafil—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000628	0.000751	CcSEcCtD
Tadalafil—Nausea—Melphalan—peripheral nervous system neoplasm	0.000628	0.000751	CcSEcCtD
Tadalafil—Dysphagia—Epirubicin—peripheral nervous system neoplasm	0.000624	0.000747	CcSEcCtD
Tadalafil—Influenza—Epirubicin—peripheral nervous system neoplasm	0.000624	0.000747	CcSEcCtD
Tadalafil—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000621	0.000743	CcSEcCtD
Tadalafil—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000618	0.00074	CcSEcCtD
Tadalafil—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000618	0.000739	CcSEcCtD
Tadalafil—Liver function test abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000617	0.000738	CcSEcCtD
Tadalafil—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000616	0.000737	CcSEcCtD
Tadalafil—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000615	0.000736	CcSEcCtD
Tadalafil—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.000612	0.000733	CcSEcCtD
Tadalafil—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.00073	CcSEcCtD
Tadalafil—Abdominal pain upper—Doxorubicin—peripheral nervous system neoplasm	0.00061	0.00073	CcSEcCtD
Tadalafil—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000608	0.000728	CcSEcCtD
Tadalafil—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000604	0.000723	CcSEcCtD
Tadalafil—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.0006	0.000718	CcSEcCtD
Tadalafil—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000599	0.000716	CcSEcCtD
Tadalafil—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000598	0.000715	CcSEcCtD
Tadalafil—Nasopharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000598	0.000715	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000597	0.000714	CcSEcCtD
Tadalafil—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000592	0.000708	CcSEcCtD
Tadalafil—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000592	0.000708	CcSEcCtD
Tadalafil—Pain—Cisplatin—peripheral nervous system neoplasm	0.000591	0.000707	CcSEcCtD
Tadalafil—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000582	0.000696	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.00058	0.000694	CcSEcCtD
Tadalafil—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.000691	CcSEcCtD
Tadalafil—Dysphagia—Doxorubicin—peripheral nervous system neoplasm	0.000578	0.000691	CcSEcCtD
Tadalafil—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000576	0.000689	CcSEcCtD
Tadalafil—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000574	0.000687	CcSEcCtD
Tadalafil—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.000569	0.00068	CcSEcCtD
Tadalafil—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000565	0.000676	CcSEcCtD
Tadalafil—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000563	0.000674	CcSEcCtD
Tadalafil—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000563	0.000673	CcSEcCtD
Tadalafil—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000561	0.000671	CcSEcCtD
Tadalafil—Infestation NOS—Epirubicin—peripheral nervous system neoplasm	0.000557	0.000666	CcSEcCtD
Tadalafil—Infestation—Epirubicin—peripheral nervous system neoplasm	0.000557	0.000666	CcSEcCtD
Tadalafil—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000556	0.000666	CcSEcCtD
Tadalafil—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000556	0.000665	CcSEcCtD
Tadalafil—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000555	0.000664	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000552	0.00066	CcSEcCtD
Tadalafil—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000552	0.00066	CcSEcCtD
Tadalafil—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000547	0.000655	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000547	0.000654	CcSEcCtD
Tadalafil—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000546	0.000653	CcSEcCtD
Tadalafil—Constipation—Etoposide—peripheral nervous system neoplasm	0.000542	0.000648	CcSEcCtD
Tadalafil—Pain—Etoposide—peripheral nervous system neoplasm	0.000542	0.000648	CcSEcCtD
Tadalafil—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000541	0.000647	CcSEcCtD
Tadalafil—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000541	0.000647	CcSEcCtD
Tadalafil—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000537	0.000642	CcSEcCtD
Tadalafil—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000537	0.000642	CcSEcCtD
Tadalafil—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000535	0.00064	CcSEcCtD
Tadalafil—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000534	0.000638	CcSEcCtD
Tadalafil—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000531	0.000635	CcSEcCtD
Tadalafil—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000525	0.000628	CcSEcCtD
Tadalafil—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00052	0.000622	CcSEcCtD
Tadalafil—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000518	0.00062	CcSEcCtD
Tadalafil—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000517	0.000619	CcSEcCtD
Tadalafil—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000516	0.000617	CcSEcCtD
Tadalafil—Infestation NOS—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000616	CcSEcCtD
Tadalafil—Infestation—Doxorubicin—peripheral nervous system neoplasm	0.000515	0.000616	CcSEcCtD
Tadalafil—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000512	0.000612	CcSEcCtD
Tadalafil—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000511	0.000612	CcSEcCtD
Tadalafil—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000511	0.000611	CcSEcCtD
Tadalafil—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000509	0.000609	CcSEcCtD
Tadalafil—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000508	0.000608	CcSEcCtD
Tadalafil—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000506	0.000606	CcSEcCtD
Tadalafil—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000503	0.000602	CcSEcCtD
Tadalafil—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000502	0.000601	CcSEcCtD
Tadalafil—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000501	0.000599	CcSEcCtD
Tadalafil—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000501	0.000599	CcSEcCtD
Tadalafil—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000599	CcSEcCtD
Tadalafil—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000501	0.000599	CcSEcCtD
Tadalafil—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.0005	0.000598	CcSEcCtD
Tadalafil—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000497	0.000595	CcSEcCtD
Tadalafil—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000497	0.000595	CcSEcCtD
Tadalafil—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000496	0.000593	CcSEcCtD
Tadalafil—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000496	0.000593	CcSEcCtD
Tadalafil—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000494	0.000591	CcSEcCtD
Tadalafil—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000494	0.00059	CcSEcCtD
Tadalafil—Rash—Vincristine—peripheral nervous system neoplasm	0.000493	0.00059	CcSEcCtD
Tadalafil—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000493	0.000589	CcSEcCtD
Tadalafil—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000589	CcSEcCtD
Tadalafil—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000491	0.000588	CcSEcCtD
Tadalafil—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000491	0.000588	CcSEcCtD
Tadalafil—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.00049	0.000586	CcSEcCtD
Tadalafil—Headache—Vincristine—peripheral nervous system neoplasm	0.00049	0.000586	CcSEcCtD
Tadalafil—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000486	0.000581	CcSEcCtD
Tadalafil—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000482	0.000577	CcSEcCtD
Tadalafil—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000473	0.000566	CcSEcCtD
Tadalafil—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.000473	0.000565	CcSEcCtD
Tadalafil—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.000467	0.000559	CcSEcCtD
Tadalafil—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.000467	0.000558	CcSEcCtD
Tadalafil—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000466	0.000557	CcSEcCtD
Tadalafil—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000556	CcSEcCtD
Tadalafil—Nausea—Vincristine—peripheral nervous system neoplasm	0.000464	0.000556	CcSEcCtD
Tadalafil—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000555	CcSEcCtD
Tadalafil—Flushing—Epirubicin—peripheral nervous system neoplasm	0.000464	0.000555	CcSEcCtD
Tadalafil—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	0.000464	0.000555	CcSEcCtD
Tadalafil—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000462	0.000553	CcSEcCtD
Tadalafil—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.00055	CcSEcCtD
Tadalafil—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	0.000459	0.000549	CcSEcCtD
Tadalafil—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000457	0.000546	CcSEcCtD
Tadalafil—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.000545	CcSEcCtD
Tadalafil—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000454	0.000544	CcSEcCtD
Tadalafil—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000454	0.000544	CcSEcCtD
Tadalafil—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000542	CcSEcCtD
Tadalafil—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000453	0.000542	CcSEcCtD
Tadalafil—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000451	0.00054	CcSEcCtD
Tadalafil—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.00045	0.000539	CcSEcCtD
Tadalafil—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000448	0.000536	CcSEcCtD
Tadalafil—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.00044	0.000526	CcSEcCtD
Tadalafil—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000438	0.000524	CcSEcCtD
Tadalafil—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	0.000437	0.000523	CcSEcCtD
Tadalafil—Rash—Cisplatin—peripheral nervous system neoplasm	0.000436	0.000522	CcSEcCtD
Tadalafil—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000436	0.000521	CcSEcCtD
Tadalafil—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.000433	0.000518	CcSEcCtD
Tadalafil—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000432	0.000517	CcSEcCtD
Tadalafil—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000431	0.000516	CcSEcCtD
Tadalafil—Flushing—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000513	CcSEcCtD
Tadalafil—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000429	0.000513	CcSEcCtD
Tadalafil—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000421	0.000503	CcSEcCtD
Tadalafil—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.00042	0.000502	CcSEcCtD
Tadalafil—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000419	0.000501	CcSEcCtD
Tadalafil—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000418	0.0005	CcSEcCtD
Tadalafil—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000418	0.0005	CcSEcCtD
Tadalafil—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000417	0.000499	CcSEcCtD
Tadalafil—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000411	0.000491	CcSEcCtD
Tadalafil—Vision blurred—Epirubicin—peripheral nervous system neoplasm	0.00041	0.00049	CcSEcCtD
Tadalafil—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000405	0.000485	CcSEcCtD
Tadalafil—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000403	0.000482	CcSEcCtD
Tadalafil—Rash—Etoposide—peripheral nervous system neoplasm	0.000399	0.000478	CcSEcCtD
Tadalafil—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000399	0.000477	CcSEcCtD
Tadalafil—Headache—Etoposide—peripheral nervous system neoplasm	0.000397	0.000475	CcSEcCtD
Tadalafil—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000391	0.000468	CcSEcCtD
Tadalafil—Syncope—Epirubicin—peripheral nervous system neoplasm	0.00039	0.000467	CcSEcCtD
Tadalafil—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000389	0.000466	CcSEcCtD
Tadalafil—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000387	0.000463	CcSEcCtD
Tadalafil—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000384	0.00046	CcSEcCtD
Tadalafil—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000382	0.000457	CcSEcCtD
Tadalafil—Cough—Epirubicin—peripheral nervous system neoplasm	0.00038	0.000454	CcSEcCtD
Tadalafil—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	0.000379	0.000454	CcSEcCtD
Tadalafil—Convulsion—Epirubicin—peripheral nervous system neoplasm	0.000377	0.000451	CcSEcCtD
Tadalafil—Nausea—Etoposide—peripheral nervous system neoplasm	0.000376	0.00045	CcSEcCtD
Tadalafil—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000376	0.000449	CcSEcCtD
Tadalafil—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000443	CcSEcCtD
Tadalafil—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000443	CcSEcCtD
Tadalafil—Myalgia—Epirubicin—peripheral nervous system neoplasm	0.00037	0.000443	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.000368	0.00044	CcSEcCtD
Tadalafil—Discomfort—Epirubicin—peripheral nervous system neoplasm	0.000366	0.000438	CcSEcCtD
Tadalafil—Dry mouth—Epirubicin—peripheral nervous system neoplasm	0.000362	0.000433	CcSEcCtD
Tadalafil—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000362	0.000433	CcSEcCtD
Tadalafil—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000361	0.000432	CcSEcCtD
Tadalafil—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000356	0.000426	CcSEcCtD
Tadalafil—Oedema—Epirubicin—peripheral nervous system neoplasm	0.000355	0.000425	CcSEcCtD
Tadalafil—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000354	0.000423	CcSEcCtD
Tadalafil—Infection—Epirubicin—peripheral nervous system neoplasm	0.000353	0.000422	CcSEcCtD
Tadalafil—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000351	0.00042	CcSEcCtD
Tadalafil—Shock—Epirubicin—peripheral nervous system neoplasm	0.000349	0.000418	CcSEcCtD
Tadalafil—Convulsion—Doxorubicin—peripheral nervous system neoplasm	0.000349	0.000417	CcSEcCtD
Tadalafil—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000348	0.000417	CcSEcCtD
Tadalafil—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000348	0.000416	CcSEcCtD
Tadalafil—Tachycardia—Epirubicin—peripheral nervous system neoplasm	0.000347	0.000415	CcSEcCtD
Tadalafil—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000345	0.000413	CcSEcCtD
Tadalafil—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	0.000343	0.000411	CcSEcCtD
Tadalafil—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.00041	CcSEcCtD
Tadalafil—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.00041	CcSEcCtD
Tadalafil—Myalgia—Doxorubicin—peripheral nervous system neoplasm	0.000343	0.00041	CcSEcCtD
Tadalafil—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.000407	CcSEcCtD
Tadalafil—Discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000339	0.000405	CcSEcCtD
Tadalafil—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	0.000335	0.000401	CcSEcCtD
Tadalafil—Hypotension—Epirubicin—peripheral nervous system neoplasm	0.000332	0.000397	CcSEcCtD
Tadalafil—Oedema—Doxorubicin—peripheral nervous system neoplasm	0.000329	0.000393	CcSEcCtD
Tadalafil—Infection—Doxorubicin—peripheral nervous system neoplasm	0.000326	0.00039	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000323	0.000387	CcSEcCtD
Tadalafil—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000323	0.000387	CcSEcCtD
Tadalafil—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000322	0.000385	CcSEcCtD
Tadalafil—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000321	0.000384	CcSEcCtD
Tadalafil—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	0.000321	0.000384	CcSEcCtD
Tadalafil—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000382	CcSEcCtD
Tadalafil—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000319	0.000381	CcSEcCtD
Tadalafil—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	0.000318	0.00038	CcSEcCtD
Tadalafil—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000317	0.000379	CcSEcCtD
Tadalafil—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000316	0.000378	CcSEcCtD
Tadalafil—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000313	0.000374	CcSEcCtD
Tadalafil—Hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000307	0.000367	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000307	0.000367	CcSEcCtD
Tadalafil—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.000306	0.000366	CcSEcCtD
Tadalafil—Pain—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000363	CcSEcCtD
Tadalafil—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000304	0.000363	CcSEcCtD
Tadalafil—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000299	0.000358	CcSEcCtD
Tadalafil—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.000297	0.000355	CcSEcCtD
Tadalafil—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000295	0.000353	CcSEcCtD
Tadalafil—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000293	0.00035	CcSEcCtD
Tadalafil—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000292	0.000349	CcSEcCtD
Tadalafil—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.00029	0.000347	CcSEcCtD
Tadalafil—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.000289	0.000346	CcSEcCtD
Tadalafil—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000284	0.000339	CcSEcCtD
Tadalafil—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000283	0.000339	CcSEcCtD
Tadalafil—Urticaria—Epirubicin—peripheral nervous system neoplasm	0.000282	0.000337	CcSEcCtD
Tadalafil—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000336	CcSEcCtD
Tadalafil—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000281	0.000336	CcSEcCtD
Tadalafil—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.000281	0.000336	CcSEcCtD
Tadalafil—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000269	0.000321	CcSEcCtD
Tadalafil—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000313	CcSEcCtD
Tadalafil—Urticaria—Doxorubicin—peripheral nervous system neoplasm	0.000261	0.000312	CcSEcCtD
Tadalafil—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.00026	0.000311	CcSEcCtD
Tadalafil—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.000255	0.000305	CcSEcCtD
Tadalafil—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000251	0.000301	CcSEcCtD
Tadalafil—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000243	0.000291	CcSEcCtD
Tadalafil—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00029	CcSEcCtD
Tadalafil—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000236	0.000282	CcSEcCtD
Tadalafil—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000235	0.000281	CcSEcCtD
Tadalafil—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000232	0.000278	CcSEcCtD
Tadalafil—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000226	0.00027	CcSEcCtD
Tadalafil—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000225	0.000269	CcSEcCtD
Tadalafil—Rash—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000268	CcSEcCtD
Tadalafil—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000224	0.000268	CcSEcCtD
Tadalafil—Headache—Epirubicin—peripheral nervous system neoplasm	0.000222	0.000266	CcSEcCtD
Tadalafil—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.00026	CcSEcCtD
Tadalafil—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000211	0.000252	CcSEcCtD
Tadalafil—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000209	0.00025	CcSEcCtD
Tadalafil—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000248	CcSEcCtD
Tadalafil—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000207	0.000248	CcSEcCtD
Tadalafil—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000206	0.000246	CcSEcCtD
Tadalafil—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.000195	0.000233	CcSEcCtD
